Logo image of CTNM

CONTINEUM THERAPEUTICS INC-A (CTNM) Stock Analyst Ratings

NASDAQ:CTNM - Nasdaq - US21217B1008 - Common Stock - Currency: USD

4.1  +0.13 (+3.27%)

Premarket: 3.85 -0.25 (-6.1%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to CTNM. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 25.3. This target is 516.98% above the current price.
CTNM was analyzed by 11 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about CTNM.
In the previous month the buy percentage consensus was at a similar level.
CTNM was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

CTNM Historical Analyst RatingsCTNM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 4.1016.1625.5025.3032.55 - 294.15% 521.95% 516.98% 693.90%

Related screens

CTNM Current Analyst RatingCTNM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2025-03-13 Jones Trading Initiate Buy
2025-03-07 Baird Maintains Outperform -> Outperform
2025-01-09 RBC Capital Reiterate Outperform -> Outperform
2024-11-07 RBC Capital Maintains Outperform -> Outperform
2024-10-22 Baird Initiate Outperform
2024-08-14 RBC Capital Maintains Outperform -> Outperform
2024-04-30 RBC Capital Initiate Outperform
2024-04-30 Stifel Initiate Buy
2024-04-30 Morgan Stanley Initiate Overweight